A cost-efficacy analysis model for anti-TNF agents in psoriatic arthritis

被引：0
|
作者：
Arjunji, RV [1 ]
Dabbous, OH [1 ]
Rahman, MI [1 ]
机构：
[1] Centocor Inc, Horsham, PA USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64393-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A27 / A28
页数：2
相关论文
共 50 条
  • [21] Drug resistance in anti-TNF therapy of psoriatic arthritis
    Wcislo-Dziadecka, Dominika Ligia
    Grabarek, Benjamin
    Brzezinska-Wcislo, Ligia
    Mazurek, Urszula
    PRZEGLAD DERMATOLOGICZNY, 2018, 105 (05): : 625 - 631
  • [22] COST ANALYSIS OF RECENTLY APPROVED AND OLDER ANTI-TNF BIOLOGIC AGENTS USED IN RHEUMATOID ARTHRITIS
    Carter, C.
    Schmeichel-Mueller, C.
    McKenzie, R. S.
    Piech, C. T.
    VALUE IN HEALTH, 2010, 13 (03) : A123 - A123
  • [23] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
    Haberhauer, Guenther
    Strehblow, Christoph
    Fasching, Peter
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224
  • [24] Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice
    Michela, Matthias
    Reguiai, Ziad
    Fauconier, Marion
    Brochot, Pascal
    Eschard, Jean-Paul
    Salmon, Jean-Hugues
    THERAPIE, 2016, 71 (03): : 281 - 286
  • [25] Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Sergio Schwartzman
    Roy Fleischmann
    G James Morgan
    Arthritis Research & Therapy, 6
  • [26] Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
    Sarzi-Puttini, P.
    Antivalle, M.
    Marchesoni, A.
    Favalli, E. G.
    Gorla, R.
    Filippini, M.
    Caporali, R.
    Bobbio-Pallavicini, F.
    Montecucco, C.
    Atzeni, F.
    REUMATISMO, 2008, 60 (04) : 290 - 295
  • [27] Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
    Schwartzman, S
    Fleischmann, R
    Morgan, GJ
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (Suppl 2) : S3 - S11
  • [28] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 395 - 395
  • [29] A cost efficacy analysis on anti-TNF therapy in ankylosing spondylitis
    Singh, G
    Tandon, N
    Bala, M
    VALUE IN HEALTH, 2004, 7 (06) : 663 - 664
  • [30] PERSISTENCE ON TREATMENT AND OPTIMIZATION AMONG ANTI-TNFα AGENTS IN PSORIATIC ARTHRITIS PATIENTS IN CLINICAL PRACTICE
    Pinto-Tasende, J.
    Alonso, E.
    Bejerano, C.
    Gromaz, J.
    Acasuso, B.
    Fernandez-Lopez, C.
    Oreiro, N.
    Acasuso, M.
    De Toro, J.
    Blanco, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1154 - 1155
12345